Our Pricing

What Does Omeprazole Do vs Gaviscon?

Published on: June 03, 2026

When comparing omeprazole vs Gaviscon UK treatments, it's essential to understand they work through completely different mechanisms. Omeprazole is a proton pump inhibitor (PPI) that reduces stomach acid production at the source, while Gaviscon forms a protective barrier to prevent acid reflux. Both are licensed in the UK for managing heartburn and acid reflux, but your choice depends on symptom severity, frequency, and underlying causes.

How Omeprazole Works for Acid Reflux

Omeprazole belongs to a class of medicines called proton pump inhibitors (PPIs), which work by blocking the enzyme system responsible for producing stomach acid [1]. Unlike antacids that neutralise existing acid, omeprazole prevents acid secretion at the cellular level, reducing overall stomach acidity by up to 90% within 24 hours of the first dose [2].

Clinical trials demonstrate that omeprazole 20mg once daily heals oesophageal inflammation in approximately 80% of patients within four weeks, making it highly effective for persistent gastro-oesophageal reflux disease (GORD) [1]. The medication requires one to four days to reach full effect, as it works gradually to suppress acid-producing cells in the stomach lining.

At Cured Pharmacy, omeprazole is available from £9.99 following a free online consultation with a UK prescriber. The treatment is particularly suited to individuals experiencing frequent heartburn (two or more episodes per week) or those with diagnosed GORD requiring long-term acid suppression.

When Omeprazole Is Recommended

UK clinical guidelines recommend PPIs like omeprazole for moderate to severe acid reflux, Barrett's oesophagus, Zollinger-Ellison syndrome, and healing of gastric or duodenal ulcers [2]. The MHRA licenses omeprazole for both short-term symptom relief and maintenance therapy, with treatment duration determined by your prescriber based on symptom response and underlying condition.

How Gaviscon Works Differently

Gaviscon contains sodium alginate, which reacts with stomach acid to form a gel-like raft that floats on top of stomach contents [3]. This physical barrier prevents acid from flowing back into the oesophagus during reflux episodes, providing rapid symptom relief without altering stomach acid production.

Unlike omeprazole, Gaviscon works within minutes and is classified as an antacid rather than a PPI. It's available over the counter without prescription and is particularly effective for occasional heartburn triggered by specific foods, large meals, or lying down after eating [3]. The protective raft lasts approximately four hours, making Gaviscon suitable for on-demand use rather than continuous acid suppression.

Because Gaviscon doesn't reduce acid production, it's generally considered safer for short-term use and carries fewer long-term risks associated with chronic acid suppression. However, it doesn't heal oesophageal damage or address the underlying causes of persistent reflux.

Omeprazole vs Gaviscon: Key Differences

The fundamental difference lies in their mechanism: omeprazole prevents acid production, while Gaviscon creates a physical barrier against existing acid. This distinction determines which treatment suits your specific situation and symptom pattern.

Omeprazole requires regular daily dosing to maintain acid suppression and takes several days to reach full effectiveness, making it ideal for chronic conditions requiring sustained control [1][2]. Gaviscon provides immediate relief but requires dosing after meals and at bedtime, making it better suited for intermittent symptoms or breakthrough heartburn whilst on PPI therapy [3].

From a regulatory perspective, omeprazole is prescription-only for doses above 20mg and requires clinical assessment to rule out serious underlying conditions like gastric cancer, particularly in patients over 55 with new or changing symptoms. Gaviscon is available without prescription but should not be used long-term without medical review, as persistent symptoms may indicate conditions requiring investigation.

Duration of Action and Onset

Gaviscon acts within three to five minutes and lasts approximately four hours per dose [3]. Omeprazole takes one to four days to achieve maximum acid suppression but provides 24-hour control with once-daily dosing [1]. This pharmacokinetic difference makes combination therapy logical for some patients—omeprazole for baseline control and Gaviscon for breakthrough symptoms.

Can You Take Omeprazole and Gaviscon Together?

Yes, omeprazole and Gaviscon can be taken together safely, and this combination is commonly recommended by UK prescribers for patients experiencing breakthrough symptoms whilst on PPI therapy [4]. There are no significant drug interactions between these medications, as they work through different mechanisms and don't interfere with each other's absorption or effectiveness.

The typical approach involves taking omeprazole once daily (usually before breakfast) to reduce overall acid production, with Gaviscon used as needed for immediate relief of breakthrough heartburn [4]. This combination provides both long-term control and rapid symptom management when required.

However, timing matters: ideally, take Gaviscon at least two hours after omeprazole to avoid any potential interference with PPI absorption. Always inform your prescriber about all medications you're taking, including over-the-counter products like Gaviscon, to ensure your treatment plan is optimised.

Choosing Between Omeprazole and Gaviscon

Your choice depends on symptom frequency, severity, and underlying diagnosis. Occasional heartburn triggered by specific foods or activities responds well to Gaviscon, whilst frequent symptoms (twice weekly or more) typically require omeprazole or another PPI for adequate control [2][4].

Consider omeprazole if you experience persistent heartburn despite lifestyle modifications, night-time symptoms disrupting sleep, difficulty swallowing, or confirmed GORD on endoscopy. These scenarios indicate a need for sustained acid suppression rather than symptom masking [1][2].

Gaviscon remains appropriate for pregnancy-related heartburn (where PPIs require careful risk-benefit assessment), occasional symptoms in otherwise healthy individuals, or as adjunct therapy alongside omeprazole. It's also preferred when rapid relief is needed, such as after a large meal or when lying down.

Treatment Selection at Cured Pharmacy

Our UK prescribers assess your symptom pattern, medical history, and red-flag features during your free online consultation to recommend the most appropriate treatment. We offer omeprazole capsules from £9.99, alongside alternative PPIs including esomeprazole, lansoprazole, and pantoprazole, all requiring clinical assessment before dispensing. Transparent pricing is displayed before consultation, with no hidden fees.

Alternative PPI Options Available

Beyond omeprazole, several other proton pump inhibitors are licensed in the UK, each with subtle differences in potency, dosing, and patient response. Esomeprazole (the S-isomer of omeprazole) demonstrates slightly superior acid suppression in some studies and is available from £9.99 at Cured Pharmacy [5].

Lansoprazole offers comparable efficacy to omeprazole with once-daily dosing and comes in both capsule and orodispersible tablet formulations, making it suitable for patients with swallowing difficulties. Available from £9.99, lansoprazole is often prescribed when omeprazole proves insufficient or causes side effects [5].

Pantoprazole provides similar acid suppression with a potentially different side effect profile, whilst branded options like Losec (omeprazole) and Nexium (esomeprazole) offer the same active ingredients as generic versions but at higher cost. Your prescriber will recommend the most suitable PPI based on your individual response, medical history, and any concurrent medications that might interact differently with specific PPIs.

Scientific References

1. Strand, D. S., Kim, D., & Peura, D. A. (2017). 25 Years of Proton Pump Inhibitors: A Comprehensive Review. Gut and Liver, 11(1), 27–37. https://doi.org/10.5009/gnl15502 [accessed 13 August 2026]
2. National Institute for Health and Care Excellence. (2019). Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management (Clinical guideline CG184). NICE. https://www.nice.org.uk/guidance/cg184 [accessed 13 August 2026]
3. Mandel, K. G., Daggy, B. P., Brodie, D. A., & Jacoby, H. I. (2000). Review article: alginate-raft formulations in the treatment of heartburn and acid reflux. Alimentary Pharmacology & Therapeutics, 14(6), 669–690. https://doi.org/10.1046/j.1365-2036.2000.00759.x [accessed 13 August 2026]
4. Katz, P. O., Gerson, L. B., & Vela, M. F. (2013). Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease. American Journal of Gastroenterology, 108(3), 308–328. https://doi.org/10.1038/ajg.2012.444 [accessed 13 August 2026]
5. Kirchheiner, J., Glatt, S., Fuhr, U., Klotz, U., Meineke, I., Seufferlein, T., & Brockmöller, J. (2009). Relative potency of proton-pump inhibitors—comparison of effects on intragastric pH. European Journal of Clinical Pharmacology, 65(1), 19–31. https://doi.org/10.1007/s00228-008-0576-5 [accessed 13 August 2026]
6. NHS. (2026). Heartburn and acid reflux. https://www.nhs.uk/conditions/heartburn-and-acid-reflux/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.